Expanding Access to Mental Healthcare Services Drives Lexapro Market Demand The Lexapro Market is witnessing substantial growth worldwide, driven by the increasing prevalence of depression, generalized anxiety disorder, and other mental health conditions. Lexapro (escitalopram), a widely prescribed selective serotonin reuptake inhibitor (SSRI), has become a cornerstone therapy for managing anxiety and depressive disorders due to its proven efficacy, favorable safety...
Join our community to interact with posts!